Your browser doesn't support javascript.
loading
Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry.
Jiménez Fonseca, Paula; Carmona-Bayonas, Alberto; Hernández, Raquel; Custodio, Ana; Cano, Juana Maria; Lacalle, Alejandra; Echavarria, Isabel; Macias, Ismael; Mangas, Monserrat; Visa, Laura; Buxo, Elvira; Álvarez Manceñido, Felipe; Viudez, Antonio; Pericay, Carles; Azkarate, Aitor; Ramchandani, Avinash; López, Carlos; Martinez de Castro, Eva; Fernández Montes, Ana; Longo, Federico; Sánchez Bayona, Rodrigo; Limón, Maria Luisa; Diaz-Serrano, Asun; Martin Carnicero, Alfonso; Arias, David; Cerdà, Paula; Rivera, Fernando; Vieitez, Jose Maria; Sánchez Cánovas, Manuel; Garrido, M; Gallego, J.
Afiliação
  • Jiménez Fonseca P; Department of Medical Oncology, Central de Asturias University Hospital, Oviedo 33011, Spain.
  • Carmona-Bayonas A; Department of Hematology and Medical Oncology, Morales Meseguer University Hospital, Murcia 30008, Spain.
  • Hernández R; Department of Medical Oncology, Canarias University Hospital, Tenerife 38320, Spain.
  • Custodio A; Department of Medical Oncology, La Paz University Hospital, Madrid 28046, Spain.
  • Cano JM; Department of Medical Oncology, Ciudad Real General Hospital, Ciudad Real 13005, Spain.
  • Lacalle A; Department of Medical Oncology, Complejo Hospitalario de Navarra, Pamplona 31008, Spain.
  • Echavarria I; Department of Medical Oncology, Gregorio Marañón University Hospital, Madrid 28007, Spain.
  • Macias I; Department of Medical Oncology, Parc Tauli University Hospital, Sabadell 08208, Spain.
  • Mangas M; Department of Medical Oncology, Hospital Galdakao-Usansolo, Galdakao-Usansolo 48960, Spain.
  • Visa L; Department of Medical Oncology, El Mar University Hospital, Barcelona 08003, Spain.
  • Buxo E; Department of Medical Oncology, Hospital Clinic, Barcelona 08036, Spain.
  • Álvarez Manceñido F; Department of Pharmacy, Central de Asturias University Hospital, Oviedo 30008, Spain.
  • Viudez A; Department of Medical Oncology, Complejo Hospitalario de Navarra, Pamplona 31008, Spain.
  • Pericay C; Department of Medical Oncology, Parc Tauli University Hospital, Sabadell 08208, Spain.
  • Azkarate A; Department of Medical Oncology, Son Espases University Hospital, Mallorca 07120, Spain.
  • Ramchandani A; Department of Medical Oncology, Insular de Gran Canaria University Hospital, Las Palmas de Gran Canaria 35016, Spain.
  • López C; Department of Medical Oncology, Marqués de Valdecilla University Hospital, Santander 39008, Spain.
  • Martinez de Castro E; Department of Medical Oncology, Marqués de Valdecilla University Hospital, Santander 39008, Spain.
  • Fernández Montes A; Department of Medical Oncology, Complejo Hospitalario de Orense, Orense 32005, Spain.
  • Longo F; Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid 28034, Spain.
  • Sánchez Bayona R; Department of Medical Oncology, Clínica Universidad de Navarra, Pamplona 31008, Spain.
  • Limón ML; Department of Medical Oncology, Virgen del Rocío University Hospital, Sevilla 41013, Spain.
  • Diaz-Serrano A; Department of Medical Oncology, 12 de Octubre University Hospital, Madrid 28041, Spain.
  • Martin Carnicero A; Department of Medical Oncology, Hospital San Millán-San Pedro, Logroño 26006, Spain.
  • Arias D; Department of Medical Oncology, Complejo Hospitalario de Orense, Orense 32005, Spain.
  • Cerdà P; Department of Medical Oncology, Tecknon Cancer Institute, Barcelona 08022, Spain.
  • Rivera F; Department of Medical Oncology, Marqués de Valdecilla University Hospital, Santander 39008, Spain.
  • Vieitez JM; Department of Medical Oncology, Central de Asturias University Hospital, Oviedo 33011, Spain.
  • Sánchez Cánovas M; Department of Hematology and Medical Oncology, Morales Meseguer University Hospital, Murcia 30008, Spain.
  • Garrido M; Department of Medical Oncology, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile.
  • Gallego J; Department of Medical Oncology, Elche University Hospital, Elche 03203, Spain.
Br J Cancer ; 117(6): 775-782, 2017 Sep 05.
Article em En | MEDLINE | ID: mdl-28765618
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Sistema de Registros Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Chile / Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Sistema de Registros Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Chile / Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha País de publicação: Reino Unido